chr2-241735267-C-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000321264.9(D2HGDH):āc.43C>Gā(p.Arg15Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00608 in 1,518,798 control chromosomes in the GnomAD database, including 403 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Synonymous variant affecting the same amino acid position (i.e. R15R) has been classified as Likely benign.
Frequency
Consequence
ENST00000321264.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
D2HGDH | NM_152783.5 | c.43C>G | p.Arg15Gly | missense_variant | 2/10 | ENST00000321264.9 | NP_689996.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
D2HGDH | ENST00000321264.9 | c.43C>G | p.Arg15Gly | missense_variant | 2/10 | 1 | NM_152783.5 | ENSP00000315351 | P1 | |
ENST00000400768.2 | n.232G>C | non_coding_transcript_exon_variant | 1/2 | 4 |
Frequencies
GnomAD3 genomes AF: 0.00840 AC: 1278AN: 152148Hom.: 49 Cov.: 34
GnomAD3 exomes AF: 0.0294 AC: 3407AN: 115976Hom.: 212 AF XY: 0.0229 AC XY: 1479AN XY: 64492
GnomAD4 exome AF: 0.00582 AC: 7957AN: 1366538Hom.: 352 Cov.: 29 AF XY: 0.00539 AC XY: 3636AN XY: 674148
GnomAD4 genome AF: 0.00839 AC: 1278AN: 152260Hom.: 51 Cov.: 34 AF XY: 0.00936 AC XY: 697AN XY: 74442
ClinVar
Submissions by phenotype
not provided Benign:4
Benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Nov 08, 2017 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Jun 10, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 05, 2021 | - - |
D-2-hydroxyglutaric aciduria 1 Benign:2
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Oct 31, 2013 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at